Mercedes plant in Tuscaloosa: The company also wants to have the GLC manufactured there. Photo: Mercedes-Benz AG Now Mercedes no longer wants to produce the current combustion engine version of the GLC in the USA, but rather the successor model. Apparently Mercedes is hoping for higher demand for the new vehicle. The current GLC was… Continue reading German Handelsblatt: Mercedes: GLC production in the USA is delayed012237
Tag: Production/Sales News
German Handelsblatt: Mercedes: GLC production in the USA is delayed012237
Mercedes plant in Tuscaloosa: The company also wants to have the GLC manufactured there. Photo: Mercedes-Benz AG Now Mercedes no longer wants to produce the current combustion engine version of the GLC in the USA, but rather the successor model. Apparently Mercedes is hoping for higher demand for the new vehicle. The current GLC was… Continue reading German Handelsblatt: Mercedes: GLC production in the USA is delayed012237
Chartis Names MOZN a Leader in Both AML and KYC Solutions — One of Only 10 Worldwide
MOZN is recognized as a Category Leader in Chartis Research’s RiskTech® Quadrant 2025 for AML Transaction Monitoring Solutions and KYC Data and Solutions. RIYADH, Saudi Arabia and LONDON, Jan. 21, 2026 /PRNewswire/ — MOZN, an enterprise AI company, today announced that its platform, FOCAL, has been named a Category Leader in Chartis Research’s RiskTech® Quadrant 2025… Continue reading Chartis Names MOZN a Leader in Both AML and KYC Solutions — One of Only 10 Worldwide
“All Access with Andy Garcia” to Highlight Ethical Surrogacy with Simple Surrogacy LLC
An upcoming segment focuses on the intersection of reproductive technology and the personal advocacy required to build modern families. LOS ANGELES, Jan. 21, 2026 /PRNewswire/ — The educational series ‘All Access with Andy Garcia’ has announced a collaboration with Simple Surrogacy, LLC for an upcoming segment focused on the methodologies of third party reproduction. Viewers… Continue reading “All Access with Andy Garcia” to Highlight Ethical Surrogacy with Simple Surrogacy LLC
Infinitopes Expands Seed Financing to $35 Million to Accelerate Clinical Development of Precision Cancer Vaccine
Financing co-led by Octopus Ventures and new investor Amplify Bio Company readies its first-in-human clinical trial of ITOP1, a precision cancer vaccine designed to prevent recurrence in oesophageal cancer OXFORD, England, Jan. 21, 2026 /PRNewswire/ — Infinitopes, a clinical-stage cancer vaccine biotechnology company, today announced the successful completion of the second close of its seed… Continue reading Infinitopes Expands Seed Financing to $35 Million to Accelerate Clinical Development of Precision Cancer Vaccine
Clarivate Reveals Top 100 Global Innovators 2026
The Top 100 organizations lead the way in innovation, contributing an exceptional 16% of the world’s highest-strength AI inventions LONDON, Jan. 21, 2026 /PRNewswire/ — Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the 15th edition of its Top 100 Global Innovators. This annual benchmark celebrates the organizations that consistently deliver high-impact… Continue reading Clarivate Reveals Top 100 Global Innovators 2026
Volvo Group Capital Markets Day 2026
GOTHENBURG, Sweden, Jan. 21, 2026 /PRNewswire/ — The Volvo Group invites institutional investors and financial analysts to the Volvo Group Capital Markets Day 2026, which is to be held in Eskilstuna, Sweden on June 10. The Capital Markets Day will begin at 9:00 a.m. CEST at Volvo Construction Equipment’s Customer Center in Eskilstuna, Sweden and… Continue reading Volvo Group Capital Markets Day 2026
Samsung Biologics reports fourth quarter and fiscal year 2025 financial results
Recorded Q4’25 revenue of KRW 1,286 billion and FY’25 revenue of KRW 4,557 billion Maintained momentum through consistent operational performance and robust client demand Strengthened foundation for long-term growth through expanded manufacturing readiness and operational scale INCHEON, South Korea, Jan. 20, 2026 /PRNewswire/ — Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO),… Continue reading Samsung Biologics reports fourth quarter and fiscal year 2025 financial results
Le groupe AM signe un protocole d’accord historique avec le gouvernement de l’Uttar Pradesh pour mettre en place un centre de calcul IA à l’échelle du GW qui permettra la démocratisation de l’IA, des agents électroniques aux jetons intelligents
DAVOS, Suisse, 21 janvier 2026 /PRNewswire/ — Le groupe AM, la principale plateforme de transition énergétique soutenue par les fondateurs du groupe Greenko, a annoncé aujourd’hui la signature d’un protocole d’accord avec l’agence Invest UP du gouvernement de l’Uttar Pradesh en vue d’établir un centre de calcul à haute performance de 1 GW (gigawatt) capable de répondre aux charges… Continue reading Le groupe AM signe un protocole d’accord historique avec le gouvernement de l’Uttar Pradesh pour mettre en place un centre de calcul IA à l’échelle du GW qui permettra la démocratisation de l’IA, des agents électroniques aux jetons intelligents
Sigrid Enters Exclusive Global Licensing and Research Collaboration to Commercialize SiPore® in Consumer Oral Health
STOCKHOLM, Jan. 21, 2026 /PRNewswire/ — Sigrid Therapeutics (Sigrid) is a Swedish, science-driven consumer health company with a primary focus on metabolic health. Following the successful launch of its first two clinically proven products — Carb Fence, designed to reduce appetite and cravings while supporting fat loss, lean muscle preservation, and post-meal blood sugar control, and Glucose Stabiliser,… Continue reading Sigrid Enters Exclusive Global Licensing and Research Collaboration to Commercialize SiPore® in Consumer Oral Health